Short-term and mid-term solutions for influenza vaccines

Lancet Infect Dis. 2018 Aug;18(8):832-833. doi: 10.1016/S1473-3099(18)30404-3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Development / methods
  • Humans
  • Influenza Vaccines / administration & dosage*
  • Influenza Vaccines / immunology
  • Influenza, Human / prevention & control*
  • Vaccines, Inactivated* / immunology

Substances

  • Influenza Vaccines
  • Vaccines, Inactivated